BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN) to Ring The Nasdaq Stock Market Closing Bell
October 16 2017 - 1:07PM
What: BioMarin Pharmaceutical, Inc.
(Nasdaq:BMRN), a world leader in developing and commercializing
innovative biopharmaceuticals for rare diseases driven by genetic
causes, will visit the Nasdaq MarketSite in Times Square in
celebration of the company’s 20th anniversary.
In honor of the occasion, Dr. Henry J. Fuchs, President
of Worldwide Research & Development, will ring the
Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Tuesday, October 17, 2017 – 3:45 p.m. to
4:00 p.m. ET
BioMarin Pharmaceutical, Inc. Media
Contact:Debra
Charlesworth415-455-7451DCharlesworth@bmrn.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About BioMarin Pharmaceutical, Inc.BioMarin is
a global biotechnology company that develops and commercializes
innovative therapies for people with serious and life-threatening
rare disorders. The company's portfolio consists of six
commercialized products and multiple clinical and pre-clinical
product candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
About Nasdaq-100 Index®The Nasdaq-100 Index,
launched in January 1985, is one of the most widely followed
benchmarks in the world. The Nasdaq-100 Index is the basis of the
PowerShares QQQ Trust (Nasdaq:QQQ) which aims to provide investment
results that, before expenses, correspond with the Nasdaq-100
Index's performance. In addition, options, futures and structured
products based on the Nasdaq-100 Index and the PowerShares QQQ
Trust trade on various exchanges.
About Nasdaq:Nasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 90
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to approximately 3,900 total listings
with a market value of approximately $12 trillion. To learn more,
visit: http://business.nasdaq.com.
-NDAQA-
Invesco QQQ Trust Series 1 (NASDAQ:QQQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Invesco QQQ Trust Series 1 (NASDAQ:QQQ)
Historical Stock Chart
From Sep 2023 to Sep 2024